The Next Big Move For The Smartest Biotech Investor

The Next Big Move For The Smartest Biotech Investor
Randal J. Kirk, worth .2 billion, is one of the only billionaires to make his money from biotech. He may just be the best biotech investor ever. He made .2 billion when he sold his New River Pharmaceuticals and its ADHD drug Vyvanse to Shire in 2007. Now he just made another score by selling his antidepressant company Clinical Data to Forest Laboratories for .2 billion, or a share in …
Read more on Forbes

Add a Comment

Your email address will not be published.